Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Applied Biosystems Solid

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 5 November 2004:
Vol. 306. no. 5698, pp. 1029 - 1032
DOI: 10.1126/science.1099420
Prev | Table of Contents | Next

Reports

Nicotine Activation of {alpha}4* Receptors: Sufficient for Reward, Tolerance, and Sensitization

Andrew R. Tapper,1 Sheri L. McKinney,1 Raad Nashmi,1 Johannes Schwarz,1,2 Purnima Deshpande,1 Cesar Labarca,1 Paul Whiteaker,3 Michael J. Marks,3 Allan C. Collins,3 Henry A. Lester1*

The identity of nicotinic receptor subtypes sufficient to elicit both the acute and chronic effects of nicotine dependence is unknown. We engineered mutant mice with {alpha}4 nicotinic subunits containing a single point mutation, Leu9' -> Ala9' in the pore-forming M2 domain, rendering {alpha}4* receptors hypersensitive to nicotine. Selective activation of {alpha}4* nicotinic acetylcholine receptors with low doses of agonist recapitulates nicotine effects thought to be important in dependence, including reinforcement in response to acute nicotine administration, as well as tolerance and sensitization elicited by chronic nicotine administration. These data indicate that activation of {alpha}4* receptors is sufficient for nicotine-induced reward, tolerance, and sensitization.

1 Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA.
2 Department of Neurology, University of Leipzig, 04103 Leipzig, Germany.
3 Institute of Behavioral Genetics, University of Colorado, Boulder, CO 80309, USA.

* To whom correspondence should be addressed. E-mail: lester{at}caltech.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Nonsynaptic Chemical Transmission Through Nicotinic Acetylcholine Receptors.
B. Lendvai and E. S. Vizi (2008)
Physiol Rev 88, 333-349
   Abstract »    Full Text »    PDF »
Mitochondrial Reactive Oxygen Species Inactivate Neuronal Nicotinic Acetylcholine Receptors and Induce Long-Term Depression of Fast Nicotinic Synaptic Transmission.
V. A. Campanucci, A. Krishnaswamy, and E. Cooper (2008)
J. Neurosci. 28, 1733-1744
   Abstract »    Full Text »    PDF »
{alpha}4* Nicotinic Receptors in preBotzinger Complex Mediate Cholinergic/Nicotinic Modulation of Respiratory Rhythm.
X. M. Shao, W. Tan, J. Xiu, N. Puskar, C. Fonck, H. A. Lester, and J. L. Feldman (2008)
J. Neurosci. 28, 519-528
   Abstract »    Full Text »    PDF »
Negative Allosteric Modulation of Nicotinic Acetylcholine Receptors Blocks Nicotine Self-Administration in Rats.
R. F. Yoshimura, D. J. Hogenkamp, W. Y. Li, M. B. Tran, J. D. Belluzzi, E. R. Whittemore, F. M. Leslie, and K. W. Gee (2007)
J. Pharmacol. Exp. Ther. 323, 907-915
   Abstract »    Full Text »    PDF »
Treatment of tobacco dependence: integrating recent progress into practice.
B. Le Foll MD PhD and T. P. George MD (2007)
Can. Med. Assoc. J. 177, 1373-1380
   Abstract »    Full Text »    PDF »
Nicotine responses in hypersensitive and knockout {alpha}4 mice account for tolerance to both hypothermia and locomotor suppression in wild-type mice.
A. R. Tapper, S. L. McKinney, M. J. Marks, and H. A. Lester (2007)
Physiol Genomics 31, 422-428
   Abstract »    Full Text »    PDF »
A neurobiological basis for nicotine withdrawal.
N. E. Grunberg (2007)
PNAS 104, 17901-17902
   Full Text »    PDF »
The Endocannabinoid Anandamide Inhibits the Function of {alpha}4beta2 Nicotinic Acetylcholine Receptors.
C. E. Spivak, C. R. Lupica, and M. Oz (2007)
Mol. Pharmacol. 72, 1024-1032
   Abstract »    Full Text »    PDF »
Association of attentional network function with exon 5 variations of the CHRNA4 gene.
G. Winterer, F. Musso, A. Konrad, G. Vucurevic, P. Stoeter, T. Sander, and J. Gallinat (2007)
Hum. Mol. Genet. 16, 2165-2174
   Abstract »    Full Text »    PDF »
CHRNA4 and Tobacco Dependence: From Gene Regulation to Treatment Outcome.
K. E. Hutchison, D. L. Allen, F. M. Filbey, C. Jepson, C. Lerman, N. L. Benowitz, J. Stitzel, A. Bryan, J. McGeary, and H. M. Haughey (2007)
Arch Gen Psychiatry 64, 1078-1086
   Abstract »    Full Text »    PDF »
Bacterial Expression, NMR, and Electrophysiology Analysis of Chimeric Short/Long-chain {alpha}-Neurotoxins Acting on Neuronal Nicotinic Receptors.
E. N. Lyukmanova, Z. O. Shenkarev, A. A. Schulga, Y. S. Ermolyuk, D. Yu. Mordvintsev, Y. N. Utkin, M. A. Shoulepko, R. C. Hogg, D. Bertrand, D. A. Dolgikh, et al. (2007)
J. Biol. Chem. 282, 24784-24791
   Abstract »    Full Text »    PDF »
Chronic Nicotine Cell Specifically Upregulates Functional {alpha}4* Nicotinic Receptors: Basis for Both Tolerance in Midbrain and Enhanced Long-Term Potentiation in Perforant Path.
R. Nashmi, C. Xiao, P. Deshpande, S. McKinney, S. R. Grady, P. Whiteaker, Q. Huang, T. McClure-Begley, J. M. Lindstrom, C. Labarca, et al. (2007)
J. Neurosci. 27, 8202-8218
   Abstract »    Full Text »    PDF »
Folding, activity and import of steroidogenic acute regulatory protein into mitochondria changed by nicotine exposure.
M. Bose, D. Debnath, Y. Chen, and H. S Bose (2007)
J. Mol. Endocrinol. 39, 67-79
   Abstract »    Full Text »    PDF »
Expression of Nicotinic Acetylcholine Receptor Subunit Genes in Non-Small-Cell Lung Cancer Reveals Differences between Smokers and Nonsmokers.
D. C.-l. Lam, L. Girard, R. Ramirez, W.-s. Chau, W.-s. Suen, S. Sheridan, V. P.C. Tin, L.-p. Chung, M. P. Wong, J. W. Shay, et al. (2007)
Cancer Res. 67, 4638-4647
   Abstract »    Full Text »    PDF »
Ca2+ Permeability of the ({alpha}4)3(beta2)2 Stoichiometry Greatly Exceeds That of ({alpha}4)2(beta2)3 Human Acetylcholine Receptors.
L. Tapia, A. Kuryatov, and J. Lindstrom (2007)
Mol. Pharmacol. 71, 769-776
   Abstract »    Full Text »    PDF »
Nicotinic and Opioid Receptor Interactions in Nicotine Addiction.
D. S. McGehee (2006)
Mol. Interv. 6, 311-314
   Abstract »    Full Text »    PDF »
Trials that Matter: Varenicline: A Designer Drug to Help Smokers Quit..
S. A. Schroeder and H. C. Sox (2006)
Ann Intern Med 145, 784-785
   Full Text »    PDF »
Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers..
A. H. Burstein, T. Fullerton, D. J. Clark, and H. M. Faessel (2006)
J. Clin. Pharmacol. 46, 1234-1240
   Abstract »    Full Text »    PDF »
Sazetidine-A, A Novel Ligand That Desensitizes {alpha}4beta2 Nicotinic Acetylcholine Receptors without Activating Them.
Y. Xiao, H. Fan, J. L. Musachio, Z.-L. Wei, S. K. Chellappan, A. P. Kozikowski, and K. J. Kellar (2006)
Mol. Pharmacol. 70, 1454-1460
   Abstract »    Full Text »    PDF »
Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers..
H. M. Faessel, B. J. Smith, M. A. Gibbs, J. S. Gobey, D. J. Clark, and A. H. Burstein (2006)
J. Clin. Pharmacol. 46, 991-998
   Abstract »    Full Text »    PDF »
Smoking Cessation With Varenicline, a Selective {alpha}4beta2 Nicotinic Receptor Partial Agonist: Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial With 1-Year Follow-up..
M. Nides, C. Oncken, D. Gonzales, S. Rennard, E. J. Watsky, R. Anziano, K. R. Reeves, and for the Varenicline Study Group (2006)
Arch Intern Med 166, 1561-1568
   Abstract »    Full Text »    PDF »
Cigarette Smoking Saturates Brain {alpha}4beta2 Nicotinic Acetylcholine Receptors..
A. L. Brody, M. A. Mandelkern, E. D. London, R. E. Olmstead, J. Farahi, D. Scheibal, J. Jou, V. Allen, E. Tiongson, S. I. Chefer, et al. (2006)
Arch Gen Psychiatry 63, 907-914
   Abstract »    Full Text »    PDF »
{alpha}4beta2 Nicotinic Receptors with High and Low Acetylcholine Sensitivity: Pharmacology, Stoichiometry, and Sensitivity to Long-Term Exposure to Nicotine.
M. Moroni, R. Zwart, E. Sher, B. K. Cassels, and I. Bermudez (2006)
Mol. Pharmacol. 70, 755-768
   Abstract »    Full Text »    PDF »
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial..
D. Gonzales, S. I. Rennard, M. Nides, C. Oncken, S. Azoulay, C. B. Billing, E. J. Watsky, J. Gong, K. E. Williams, K. R. Reeves, et al. (2006)
JAMA 296, 47-55
   Abstract »    Full Text »    PDF »
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial..
D. E. Jorenby, J. T. Hays, N. A. Rigotti, S. Azoulay, E. J. Watsky, K. E. Williams, C. B. Billing, J. Gong, K. R. Reeves, and for the Varenicline Phase 3 Study Group (2006)
JAMA 296, 56-63
   Abstract »    Full Text »    PDF »
Differential Regulation of Mesolimbic {alpha}3/{alpha}6beta2 and {alpha}4beta2 Nicotinic Acetylcholine Receptor Sites and Function after Long-Term Oral Nicotine to Monkeys.
S. E. McCallum, N. Parameswaran, T. Bordia, H. Fan, J. M. McIntosh, and M. Quik (2006)
J. Pharmacol. Exp. Ther. 318, 381-388
   Abstract »    Full Text »    PDF »
Enhanced expression of hypersensitive {alpha}4* nAChR in adult mice increases the loss of midbrain dopaminergic neurons.
J. Schwarz, S. C. Schwarz, O. Dorigo, A. Stutzer, F. Wegner, C. Labarca, P. Deshpande, J. S. Gil, A. J. Berk, and H. A. Lester (2006)
FASEB J 20, 935-946
   Abstract »    Full Text »    PDF »
Iptakalim as a Human Nicotinic Acetylcholine Receptor Antagonist.
J. Hu, K. Lindenberger, G. Hu, H. Wang, R. J. Lukas, and J. Wu (2006)
J. Pharmacol. Exp. Ther. 316, 914-925
   Abstract »    Full Text »    PDF »
Novel Seizure Phenotype and Sleep Disruptions in Knock-In Mice with Hypersensitive {alpha}4* Nicotinic Receptors.
C. Fonck, B. N. Cohen, R. Nashmi, P. Whiteaker, D. A. Wagenaar, N. Rodrigues-Pinguet, P. Deshpande, S. McKinney, S. Kwoh, J. Munoz, et al. (2005)
J. Neurosci. 25, 11396-11411
   Abstract »    Full Text »    PDF »
Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human {alpha}4{beta}2 Acetylcholine Receptors.
A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom (2005)
Mol. Pharmacol. 68, 1839-1851
   Abstract »    Full Text »    PDF »
Structural Determinants of {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Trafficking.
X.-Q. Ren, S.-B. Cheng, M. W. Treuil, J. Mukherjee, J. Rao, K. H. Braunewell, J. M. Lindstrom, and R. Anand (2005)
J. Neurosci. 25, 6676-6686
   Abstract »    Full Text »    PDF »
The Effects of Subunit Composition on the Inhibition of Nicotinic Receptors by the Amphipathic Blocker 2,2,6,6-Tetramethylpiperidin-4-yl Heptanoate.
R. L. Papke, J. D. Buhr, M. M. Francis, K. I. Choi, J. S. Thinschmidt, and N. A. Horenstein (2005)
Mol. Pharmacol. 67, 1977-1990
   Abstract »    Full Text »    PDF »
Ethnic- and gender-specific association of the nicotinic acetylcholine receptor {alpha}4 subunit gene (CHRNA4) with nicotine dependence.
M. D. Li, J. Beuten, J. Z. Ma, T. J. Payne, X.-Y. Lou, V. Garcia, A. S. Duenes, K. M. Crews, and R. C. Elston (2005)
Hum. Mol. Genet. 14, 1211-1219
   Abstract »    Full Text »    PDF »
Nicotinic Receptor Subtypes in Rat Hippocampal Slices Are Differentially Sensitive to Desensitization and Early in Vivo Functional Up-Regulation by Nicotine and to Block by Bupropion.
M. Alkondon and E. X. Albuquerque (2005)
J. Pharmacol. Exp. Ther. 313, 740-750
   Abstract »    Full Text »    PDF »
Craving nicotine: It's in the genes.
D. Secko (2005)
Can. Med. Assoc. J. 172, 175-176
   Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT

To Advertise     Find Products